跳至主要内容
临床试验/NCT00929097
NCT00929097Unknown不适用

Implementation of Guidelines on Hereditary or Familial Colorectal Cancer Risk Calculation and Risk Communication

ZonMw: The Netherlands Organisation for Health Research and Development0 个研究点目标入组 300 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
主要终点
The number of colorectal cancer patients following the most optimal follow up program according to the guidelines.

研究概览

简要总结

The aim of this study is to improve clinicians' calculation, interpretation and communication of familial colorectal cancer risk, as well as patients' risk perception and uptake of referral for genetic counselling or for surveillance by colonoscopy for their relatives at risk.

详细描述

Regular colonoscopy is effective in reducing morbidity and mortality due to colorectal cancer (CRC) in patients at increased familial CRC risk. Currently, the majority of these at-risk individuals are not properly referred for increased surveillance by colonoscopy or genetic counselling. In 2008, a national multidisciplinary evidence-based guideline on familial and hereditary CRC was launched in the Netherlands. Clinicians have new tasks in familial CRC risk calculation, interpretation and communication. A clustered randomized controlled trial including an effect, process and cost evaluation will be conducted in eighteen Dutch hospitals to determine the most cost effective way to implement these new guidelines.

Surgeons and gastroenterologists in both the intervention group and the control group will receive background information on familial colorectal cancer risk and the guidelines. Patients and clinicians in the intervention group will receive an additional intervention strategy.

The effect evaluation is done by assessing the number of CRC patients for whom correct risk calculation, interpretation and communication is performed, as well as patients' uptake of the recommended follow up policy. The actual exposure to the different elements of the implementation procedure and the experiences of users will be assessed in the process evaluation. The costs of the implementation procedure will be determined by means of a cost evaluation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of colorectal cancer before the age of 70
  • Diagnosed in one of the participating hospitals
  • Able to read and understand Dutch

排除标准

  • Previous referral for genetic counseling

结局指标

主要结局

The number of colorectal cancer patients following the most optimal follow up program according to the guidelines.

时间窗: 1 year

次要结局

  • The number of patients for whom MSI testing was performed based on the MIPA criteria(1 year)
  • The number of CRC patients for whom a correct familial CRC risk is calculated by clinicians (as compared to formally calculated risks)(1 year)
  • The number of CRC patients for whom a calculated familial CRC risk is correctly interpreted by clinicians(1 year)
  • The number of CRC patients with whom a calculated familial CRC risk and/or follow up policy is communicated by clinicians(1 year)
  • Patients' uptake of the follow up policy(1 year)
  • Actual exposure to the different elements of the implementation strategy(1 year)
  • Experiences of clinicians and patients with the different elements of the implementation strategy(1 year)
  • Costs of the implementation procedure(1 year)

研究者

发起方
ZonMw: The Netherlands Organisation for Health Research and Development
申办方类型
Other

相似试验